PPT-Post-arrival TB Screening of the High-Risk

Refugees and Immigrants in Maryland Natasha Chida MD MSPH Baltimore City Health Department March 22 nd 2016 Objectives Review TB disease and infection among foreignborn persons in the United States and Maryland . Diane Bild, MD, MPH. Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention. FINANCIAL . DISCLOSURE:. None. UNLABELED/UNAPPROVED USES DISCLOSURE:. None. Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention . The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific Region. Manila. Philippines. 9-12 December 2014. TB Screening Policies . NTP Manual of Procedures (2013). Muhieddine Seoud, MD, FACOG, FACS. American University of Beirut Medical Center. Department of Obstetrics and Gynecology. Kuwait City, Lebanon February 7 2017. Screening For Ovarian Cancer In Low Risk Women: . Dr. Ruth . Heisey. Family Physician/GP Oncologist. Women’s College Hospital/Princess Margaret . Cancer Centre. Clinician Investigator/Associate Professor. University of Toronto. Sandy Fawcett . RN(EC) NP-Adult. Alon Z. Weizer, MD, MS. Associate Professor of Urology. Associate Chair, Surgical Services, . Department of Urology, University of Michigan. Disclosures. Summus (eConsult Platform): Advisory Board. Outline. Colorectal Cancer (CRC). Incidence. 2. nd. commonest cause of cancer deaths in males. 3. rd. commonest cause of cancer deaths in females. Lifetime risk. 2015 (Canada). 25,000 People diagnosed with CRC (45/100,000). March 4, 2016. Objectives. Review . current recommendations for cancer screening for . average risk. patients . by age. Identify . high risk. patients who are . candidates for cancer risk assessment with a genetic counselor. Background:. CRC. : . fourth. . most. common . cancer. . worldwide. . Background:. Malignancy. . is. . one. of the . leading. cause of . death. in SOT . recipients. CRC: from . no . association. Be thoughtful. This is not meant to be “Thou shalt not….” but a gentle nudge. There is a science to medicine, but there is also an art. Sometimes you should “break the rules.”. Please also have a discussion with your supervising provider about their thoughts if appropriate. . problem!! Objectives Recognize the rationale for changing guidelines Use correct terminology for recommending cervical cancer screening and discussing resultsInterpret results of Pap smea Stuart Salfinger. Gynaecologic Oncologist. MBBS, FRANZCOG, CGO, Dip . Surg. Ed. Ovarian Carcinoma. Leading cause fatality gynaecologic cancer. Incidence 1.5% lifetime risk. 75% present stage 3+. Stage 3 disease 30% 5 year survival. What to do for the young, old, dense and high-risk. Anna N. Wilkinson, MSc., MD, CCFP, FCFP. Associate Professor, University of Ottawa. Family Physician, The Ottawa Academic Family Health Team. GP Oncologist, The Ottawa Hospital Cancer Centre. take 2. “To err is human”. . Dr. E Holbeach. HMO supervisor. April 2017. Sign up!. CASE 1. 66 . yo. male. Travelling to visit family in Australia. PHx. :. IHD. Arthritis. Meds. ‘bought from local market in home town’. . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. .